Literature DB >> 24861842

Escherichia fergusonii.

W Gaastra1, J G Kusters2, E van Duijkeren3, L J A Lipman4.   

Abstract

Escherichia fergusonii was introduced in the genus Escherichia almost 65 years later than Escherichia coli after which the genus was named. From then (1985) onwards mainly case reports on E. fergusonii associated with disease in individuals of veterinary or human origin have been reported and only very few more extensive studies became available. This has resulted in very fragmented knowledge on this organism. The aim of this manuscript is to give an overview of what is known on E. fergusonii today and to stimulate more research on this organism so that better insight can be obtained in the role that E. fergusonii plays in human and animal infections.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Escherichia coli; Escherichia fergusonii; Infectious agent; Pathogenicity

Mesh:

Substances:

Year:  2014        PMID: 24861842     DOI: 10.1016/j.vetmic.2014.04.016

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  18 in total

1.  Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Authors:  Ya-Long Feng; Gang Cao; Dan-Qian Chen; Nosratola D Vaziri; Lin Chen; Jun Zhang; Ming Wang; Yan Guo; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2019-05-30       Impact factor: 9.261

2.  Multiplex polymerase chain reaction for identification of Escherichia coli, Escherichia albertii and Escherichia fergusonii.

Authors:  Rebecca L Lindsey; L Garcia-Toledo; D Fasulo; L M Gladney; N Strockbine
Journal:  J Microbiol Methods       Date:  2017-06-06       Impact factor: 2.363

3.  Selection of Multidrug-Resistant Enterobacteria in Weaned Pigs and Its Association With In-feed Subtherapeutic Combination of Colistin and Tylosin.

Authors:  Marlon do V Barroso; Juliana S da Silva; Sofia M Moreira; Yasmin N V Sabino; Gabriel C Rocha; Maria A S Moreira; Denise M S Bazzolli; Hilário C Mantovani
Journal:  Curr Microbiol       Date:  2022-10-08       Impact factor: 2.343

4.  Enhanced Antibiotic Tolerance of an In Vitro Multispecies Uropathogen Biofilm Model, Useful for Studies of Catheter-Associated Urinary Tract Infections.

Authors:  Jiapeng Hou; Lutian Wang; Martin Alm; Peter Thomsen; Tor Monsen; Madeleine Ramstedt; Mette Burmølle
Journal:  Microorganisms       Date:  2022-06-13

5.  Dietary switch to Western diet induces hypothalamic adaptation associated with gut microbiota dysbiosis in rats.

Authors:  Véronique Douard; Gaëlle Boudry; Mélanie Fouesnard; Johanna Zoppi; Mélanie Petera; Léa Le Gleau; Carole Migné; Fabienne Devime; Stéphanie Durand; Alexandre Benani; Samuel Chaffron
Journal:  Int J Obes (Lond)       Date:  2021-03-13       Impact factor: 5.095

6.  Genome-wide genetic marker analysis and genotyping of Escherichia fergusonii strain OTSVEF-60.

Authors:  Otun Saha; Nadira Naznin Rakhi; M Nazmul Hoque; Munawar Sultana; M Anwar Hossain
Journal:  Braz J Microbiol       Date:  2021-02-16       Impact factor: 2.476

7.  Draft Whole-Genome Sequences of Escherichia fergusonii Strains Isolated from Beef Trim (GTA-EF02), Ground Beef (GTA-EF03), and Chopped Kale (GTA-EF04).

Authors:  Paul Manninger; Adam Koziol; Catherine D Carrillo
Journal:  Genome Announc       Date:  2016-04-14

8.  The first report of Escherichia fergusonii isolated from non-human primates, in Africa.

Authors:  Barbara Glover; Jeanette Wentzel; Akinbowale Jenkins; Moritz Van Vuuren
Journal:  One Health       Date:  2017-05-04

9.  Hierarchical sets: analyzing pangenome structure through scalable set visualizations.

Authors:  Thomas Lin Pedersen
Journal:  Bioinformatics       Date:  2017-06-01       Impact factor: 6.937

10.  Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease.

Authors:  Mangesh V Suryavanshi; Shrikant S Bhute; Rahul P Gune; Yogesh S Shouche
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.